Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with…

By M. Sasso, M. Beaugrand, V. de Lédinghen, C. Douvin, P. Marcellin, R. Poupon, L. Sandrin, V. Miette. Ultrasound in Medicine and Biology, 2010

841 citations recorded by the source corpus.

Subfields: Animal Science and Zoology, Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/79d3cc1455f66805a58b5c30079955e94126be1a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Vincent Wai-Sun Wong
2. Y. Sumida
3. Asociacion Latinoamericana para el Estudio del Higado

In Hepatology

1. Y. Sumida
2. Asociacion Latinoamericana para el Estudio del Higado

Citations in the corpus

• Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. (2016, background): “8 (CAP), which is based on the properties of ultrasonic signals acquired using TE [14].”
• Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. (2017, methodology): “545 [22] Sasso M, Beaugrand M, Ledinghen V de, Douvin C, Marcellin P, Poupon R et al.”